SUDARSHAN PHARMA INDUSTRIES LI Share Price

SUDARSHAN PHARMA INDUSTRIES LI Share Price

BSE: 543828
|
Pharmaceuticals
|
S Cap
₹ 40.00
+₹0.14 (0.35%)
1D
Last updated 23 Sep, 2026, 15:28 IST

SUDARSHAN PHARMA INDUSTRIES LI Share Price Today

As of 24 Sep 2026, SUDARSHAN PHARMA INDUSTRIES LI share price is ₹40.00. The stock opened at ₹39.35, compared to its previous close of ₹39.86. During today's trading session, SUDARSHAN PHARMA INDUSTRIES LI share price moved in the range of ₹39.00 to ₹40.01, with an average price of ₹39.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹18.50 and a high of ₹42.79.

₹39.00
0.35% up today
₹40.01
1D LOW
1D HIGH

SUDARSHAN PHARMA INDUSTRIES LI Returns Calculator

Circuit
L
H
₹37.87
₹41.85
52-week
L
H
₹18.50
₹42.79

About SUDARSHAN PHARMA INDUSTRIES LI

SUDARSHAN PHARMA INDUSTRIES LI Share Price
ISIN
INE00TV01023
Sector Market Cap
₹ 995.14 Cr

Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.

SUDARSHAN PHARMA INDUSTRIES LI Financial Highlights

  • Revenue: SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹711.77 crore in FY26 vs ₹507.70 crore in FY25. It showed an increase of 40.19% on a yearly basis.
  • Operating Profit: SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹30.54 crore in FY26 vs ₹20.02 crore in FY25. It showed an increase of 52.55% on a year-on-year basis.
  • Net Profit: SUDARSHAN PHARMA INDUSTRIES LI reported a net profit of ₹23.37 crore in FY26 vs ₹14.97 crore in FY25. It showed an increase of 56.11% on a yearly basis.

SUDARSHAN PHARMA INDUSTRIES LI Quarterly Result Highlights

  • SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹175.64 crore in Jun 2026, compared with ₹225.05 crore in Mar 2026, representing a decrease of 21.96% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹7.51 crore in Jun 2026, compared with ₹15.70 crore in Mar 2026, representing a decrease of 52.17% on a quarter-on-quarter (QoQ) basis.
  • SUDARSHAN PHARMA INDUSTRIES LI reported a profit of ₹5.61 crore in Jun 2026, compared with ₹11.39 crore in Mar 2026, reflecting a decrease of 50.75% on a QoQ basis.
  • The earnings per share (EPS) of SUDARSHAN PHARMA INDUSTRIES LI stood at ₹0.66 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
58.93%
FII
19.87%
Other DII
0.00%
Retail and other
21.20%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202519.78%
Mar 202619.95%
Jun 202619.38%
Aug 202619.87%
Mkt Cap Cr
995.14
P/E
39.86
P/B
5.84
ROE
15.03%
D/E
1.85
ROCE
12.76%
Div. Yield
0.00%
EPS(TTM)
0.91
Turnover
1.16
EV/EBITDA
19.74
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.90%
Quick Ratio
0.00
Curr. Ratio
2.81
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Sudarshan Pharma outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Sudarshan Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Sudarshan Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Pidilite Industries1,59,967.0059.7814.7722.61%0.0329.97%104.710.73%0.9823.43
SRF75,117.0034.755.3513.07%0.2713.18%426.520.36%0.6558.18
Linde India53,625.8098.1512.5712.87%0.0217.16%495.720.19%0.4664.59
Gujarat Fluorochemicals49,324.9082.216.317.13%0.228.93%647.230.07%0.4761.69
Navin Fluorine43,302.4054.8410.8916.69%0.0318.14%714.370.10%0.5696.03
Godrej Industries37,031.7016.763.3111.10%6.259.34%52.520.00%0.361.81
Himadri Speciality Chemicals33,763.6041.897.1615.96%0.1619.45%91.620.12%0.7515.05
Deepak Nitrite21,985.9028.063.779.43%0.0210.74%235.740.47%0.7413.85
Aether Industries21,800.0092.698.888.94%0.1510.61%181.530.00%0.3313.09
Castrol India2,596.4418.7510.0646.94%0.0471.77%18.397.03%1.729.60

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SUDARSHAN PHARMA INDUSTRIES LI Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹505.05₹463.54₹461.33₹357.09
Other Income₹2.52₹2.61₹1.12₹0.46
Total Revenue₹507.57₹466.15₹462.45₹357.56
Total Expenses₹483.12₹450.92₹452.95₹350.42
Profit Before Tax₹21.63₹15.23₹9.50₹7.14
Tax₹5.68₹3.77₹2.46₹1.89
Profit After Tax₹15.95₹11.46₹7.04₹5.25
EPS - Basic₹0.66₹4.76₹5.48₹5.46
EPS - Diluted₹0.66₹4.76₹5.48₹5.46

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹21.63₹15.23₹9.50₹7.14
Income before WC changes₹41.64₹24.63₹15.32₹11.18
Change in Assets-₹100.01-₹52.18-₹57.56-₹42.96
Change in Liabilities₹96.53₹35.72₹15.56₹29.72
Change in WC-₹3.48-₹16.46-₹42.00-₹13.24
Cash flow from Operations₹35.22₹6.01-₹28.79-₹3.82
Cash flow from Investing-₹20.41-₹5.49-₹25.65-₹1.46
Cash flow from Financing-₹14.45-₹12.10₹65.93₹4.26
Total Cash Flow₹0.37-₹11.58₹11.48-₹1.02
Cash (Start of the year)₹0.14₹11.72₹0.24₹1.25
Cash (End of the year)₹0.55₹0.14₹11.72₹0.24

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹67.56₹41.55₹33.86₹7.94
Current Assets₹334.85₹241.57₹198.62₹129.58
Total Assets₹402.41₹283.13₹232.48₹137.52
Current Liabilities₹259.69₹160.82₹118.48₹102.62
Net Current Asset₹75.15₹80.75₹80.14₹26.96
Non-Current Liabilities₹11.23₹10.59₹13.03₹5.12
Equity Capital₹131.48₹111.71₹100.97₹29.78
Total Equity & Liabilities₹402.41₹283.13₹232.48₹137.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹502.51₹465.56₹461.33₹357.09
Other Income₹2.88₹2.75₹1.12₹0.46
Total Revenue₹505.38₹468.31₹462.45₹357.56
Total Expenses₹481.28₹453.22₹452.95₹350.42
Profit Before Tax₹21.29₹15.10₹9.50₹7.14
Tax₹5.41₹3.74₹2.46₹1.89
Profit After Tax₹15.88₹11.36₹7.04₹5.25
EPS - Basic₹0.66₹0.47₹5.48₹5.46
EPS - Diluted₹0.66₹0.47₹5.48₹5.46

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹21.29₹15.10₹9.50₹7.14
Income before WC changes₹40.21₹24.42₹15.32₹11.22
Change in Assets-₹95.54-₹55.03-₹57.56-₹42.85
Change in Liabilities₹93.07₹42.42₹15.56₹29.71
Change in WC-₹2.46-₹12.62-₹42.00-₹13.15
Cash flow from Operations₹34.91₹9.69-₹28.79-₹3.70
Cash flow from Investing-₹20.24-₹9.08-₹25.65-₹1.54
Cash flow from Financing-₹14.41-₹12.18₹65.93₹4.31
Total Cash Flow₹0.26-₹11.58₹11.48-₹0.93
Cash (Start of the year)₹0.13₹11.71₹0.23₹1.15
Cash (End of the year)₹0.39₹0.13₹11.71₹0.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹66.57₹43.99₹33.96₹8.04
Current Assets₹333.83₹240.85₹198.51₹129.47
Total Assets₹400.40₹284.84₹232.47₹137.51
Current Liabilities₹257.98₹162.27₹118.46₹102.61
Net Current Asset₹75.85₹78.58₹80.05₹26.86
Non-Current Liabilities₹11.10₹10.96₹13.03₹5.12
Equity Capital₹131.31₹111.62₹100.98₹29.78
Total Equity & Liabilities₹400.40₹284.84₹232.47₹137.51
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
0
Neutral
5
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
54.63
Neutral
ATR (14)
1.7
Neutral
STOCH(9,6)
62.76
Neutral
STOCH RSI (14)
16.2
Bullish
ADX(9)
17.91
Bullish
UO(9)
54.12
Neutral
ROC(12)
1.47
Bullish
WillR(14)
-53.88
Neutral
Period
Simple value
Exponential vaue
5D
39.87
39.9
10D
39.8
39.85
20D
39.83
39.53
50D
38.62
38.54
100D
36.98
36.43
Volume trend — traded volume by day
23 Sep1L
22 Sep1L
21 Sep1L
18 Sep5L
17 Sep1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SUDARSHAN PHARMA INDUSTRIES LI Share Price
SUDARSHAN PHARMA INDUSTRIES LI
Pharmaceuticals
Add Stock
Add Another

SUDARSHAN PHARMA INDUSTRIES LI Share Price FAQs

SUDARSHAN PHARMA INDUSTRIES LI share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837